Skip to content
10-Q

Quarterly Report

Evolent Health, Inc. EVH

0001628908-26-000033

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 112.48M sh
Shares Diluted Q1 2026 · Mar 31, 2026 111.91M sh
Shares Diluted Q1 2026 · Mar 31, 2025 115.32M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$984K
Operating Cash Flow Q1 2026 · Mar 31, 2025 $4.57M
Long Term Debt Q1 2026 · Mar 31, 2026 $973.49M
Long Term Debt Q1 2026 · Dec 31, 2025 $970.54M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $142.03M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $151.86M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $246.55M
Stockholders Equity Q1 2026 · Mar 31, 2026 $396.39M
Stockholders Equity Q1 2026 · Dec 31, 2025 $415.19M
Stockholders Equity Q1 2026 · Mar 31, 2025 $935.52M
Stockholders Equity Q1 2026 · Dec 31, 2024 $1B
Current Liabilities Q1 2026 · Mar 31, 2026 $381.24M
Current Liabilities Q1 2026 · Dec 31, 2025 $385.26M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.48B
Total Liabilities Q1 2026 · Dec 31, 2025 $1.48B
Current Assets Q1 2026 · Mar 31, 2026 $502.01M
Current Assets Q1 2026 · Dec 31, 2025 $506.37M
Total Assets Q1 2026 · Mar 31, 2026 $1.88B
Total Assets Q1 2026 · Dec 31, 2025 $1.9B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.24
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.63
Eps Basic Q1 2026 · Mar 31, 2026 −$0.24
Eps Basic Q1 2026 · Mar 31, 2025 −$0.63
Sga Expense Q1 2026 · Mar 31, 2026 $72.82M
Sga Expense Q1 2026 · Mar 31, 2025 $78.41M
Net Income Q1 2026 · Mar 31, 2026 −$26.63M
Net Income Q1 2026 · Mar 31, 2025 −$64.62M
Operating Income Q1 2026 · Mar 31, 2026 −$10.6M
Operating Income Q1 2026 · Mar 31, 2025 −$1.62M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $412.47M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $381.18M
Revenue Q1 2026 · Mar 31, 2026 $496.25M
Revenue Q1 2026 · Mar 31, 2025 $483.65M